Emerging at the intersection of biotechnology and artificial intelligence, Absci is positioning itself as a transformative entity in the drug discovery landscape. This strategic positioning comes as the company recently announced a significant $50 million capital raise, a maneuver that underscores
Massachusetts Biomedical Initiatives (MBI) has emerged as a notable force in biotech innovation through its groundbreaking Spark program, which highlights how startups are reshaping medical innovations. This nonprofit biotech accelerator recently concluded its eight-week program with outstanding
The pharmaceutical industry stands on the brink of a technological revolution with the recent release of the Good Automated Manufacturing Practice (GAMP) Artificial Intelligence Guide by the International Society for Pharmaceutical Engineering (ISPE). As pharmaceutical companies increasingly turn
The cell and gene therapy (CGT) market is undergoing rapid expansion as it transforms healthcare with innovative treatments for previously incurable diseases. This exhilarating growth is projected to reach $28 billion by the year 2030, marking a significant milestone. Experts attribute this
At the crossroads of artificial intelligence and biology lies a transformative opportunity poised to redefine the boundaries of medical science. The GREmLN initiative, spearheaded by the Chan Zuckerberg Initiative in collaboration with New York Biohub, aims to bridge these two disciplines in a
In a decisive leap toward revolutionizing gene therapy, ProBio has unveiled its cutting-edge facility in Hopewell, New Jersey. This facility is poised to become a key player in the production of high-quality plasmid, lentiviral, and adeno-associated viral vectors tailored for genomic medicine. With
